Creative Touch Permanent Makeup and Aesthetics

LED therapy (LEDT) is one of the most mechanistically well-characterised non-invasive treatments in aesthetic practice – yet also one of the most commonly misunderstood, both by clients who perceive it as simply “light on the face” and by practitioners who reduce it to “red light for collagen, blue light for acne.” The biological reality is considerably more structured than this. Each clinically relevant wavelength activates a distinct photoreceptor class, initiates a distinct intracellular signalling cascade, and produces distinct cellular outcomes – some convergent, some in direct opposition. ^[7] Red light accelerates skin barrier recovery following disruption; blue light delays it – a distinction with direct consequences for post-procedure protocol design that rarely appears in LED treatment literature. Understanding LED at the mechanism level resolves these apparent contradictions and enables wavelength selection, sequencing, and dosing decisions that are grounded in photobiology rather than general guidance. Central to all non-blue wavelength mechanisms is the same mitochondrial target discussed in the Mitochondria entity: cytochrome c oxidase, the Complex IV enzyme of the electron transport chain whose photoactivation by red and near-infrared photons initiates a cascade from energy restoration to collagen synthesis to epidermal renewal – a dermis-up mechanism in which the skin surface improves because the dermal energy infrastructure supporting it has been restored. ^[8]

LED light therapy is a form of photobiomodulation (PBM) – the use of non-ionising light at specific wavelengths and doses to modify biological processes in living tissue. Three properties distinguish it from other light-based aesthetic treatments:

Non-coherent: LED light is not laser light. Laser sources produce coherent, collimated, monochromatic light – all photons in phase, travelling in the same direction, at a precise single wavelength. LED sources produce incoherent light – photons not in phase, diverging spatially – across a defined but not mathematically precise wavelength band (typically ±10–20nm of the nominal wavelength). For photobiomodulation, coherence is not required for biological effect – the photoreceptors that initiate cellular responses respond to photon energy at the relevant wavelength regardless of coherence. ^[3]

Non-thermal: LED therapy operates at fluences (energy doses) that do not produce measurable tissue heating – the mechanism is photochemical, not photothermal. This is fundamentally different from all ablative and non-ablative thermal treatments ( RF microneedling, FTL, IPL): there is no controlled injury, no thermal denaturation, no wound-healing cascade activation, and no recovery time from thermal damage. The biological response is purely cellular metabolic – existing cells are photochemically stimulated to increase their synthetic output, not replaced or remodelled through injury. This distinction has direct implications for contraindications and for how LED is combined with thermal treatments.

Dose-dependent: LED therapy obeys the Arndt-Schulz law of photobiomodulation: biological response follows a biphasic dose-response curve. At sub-threshold fluence, no meaningful biological effect occurs. At optimal fluence, photoreceptors are activated and full cellular responses proceed. At supraphysiological fluence, inhibitory effects predominate – the same pathway that is stimulated at low dose is suppressed at high dose. This biphasic relationship means that “more light” is not better, and that clinical device calibration for irradiance, treatment distance, and session duration is not merely a safety consideration but a therapeutic efficacy requirement. ^[6]

The Three Photoreceptor Classes

The Guo & Yuan 2025 review (PMID 40751922) characterises LED light’s biological interactions across three photoreceptor classes in skin cells – a more complete model than the cytochrome c oxidase framework alone: ^[3]

1. Cytochrome c oxidase: The primary and most extensively characterised photoacceptor for red (630–660nm) and near-infrared (810–850nm) wavelengths. Cytochrome c oxidase (CCO) is the Complex IV enzyme of the mitochondrial electron transport chain – a large, copper and haem-containing enzyme that accepts electrons from cytochrome c and transfers them to molecular oxygen, completing the ETC and driving the proton gradient that powers ATP synthesis. Under normal cellular conditions, CCO activity is partially inhibited by nitric oxide (NO) binding competitively to its oxygen-binding site. Red and NIR photons absorbed by CCO’s copper centres photodissociate this inhibitory NO, restoring electron transfer rate, improving the proton gradient, and increasing ATP production – whilst simultaneously reducing the superoxide escape from impaired ETC complexes that generates endogenous ROS. ^[8]

2. Opsins: G-protein coupled receptors classically associated with retinal photoreception, but expressed in keratinocytes, fibroblasts, and melanocytes throughout the skin. Cutaneous opsins respond to specific visible wavelengths and regulate cAMP second messenger signalling, cell proliferation, pigmentation responses, and barrier function independently of the mitochondrial pathway. The opsin mechanism is less extensively characterised in the skin photobiomodulation literature than CCO, but provides a mechanistic explanation for wavelength-specific effects – particularly in the yellow-amber range – that CCO activation alone does not fully account for. ^[3]

3. Cryptochromes: Flavoprotein photoreceptors that function as core components of the skin circadian clock (CLOCK/BMAL1 transcriptional feedback loop), expressed in skin cells and responsive primarily to blue wavelengths. Blue light activation of cutaneous cryptochromes connects LED therapy to circadian regulation of skin repair, immune activation, and keratinocyte differentiation timing. The cryptochrome pathway is the most recently characterised of the three classes and carries the greatest uncertainty in terms of clinical relevance – it is worth noting as an emerging mechanistic dimension without overstating the current evidence base. ^[3]

Red Light (630–660nm): The Dermis-Up Mechanism

Red light in the 630–660nm range is the wavelength category with the deepest and most replicated clinical evidence base in LED photobiomodulation. Its mechanism operates in a sequential cascade from mitochondrial activation to epidermal renewal – a bottom-up chain that explains why consistent red LED treatment produces surface skin quality improvements that are not attributable to any direct keratinocyte photostimulation. ^[8]

The cascade:

1. CCO photodissociation → increased ETC efficiency → elevated ATP in dermal fibroblasts
2. Elevated ATP → TGF-β release from fibroblasts; ATP also activates AKT pathway signalling
3. TGF-β → fibroblast collagen I synthesis – upregulation of COL1A1 and COL3A1 gene expression confirmed in fibroblast culture and skin explant models
4. Collagen I accumulation in the dermis → integrin signalling in basal keratinocytes – the expanding collagen matrix increases mechanical resistance, activating keratinocyte surface integrins
5. Integrin activation → increased keratinocyte proliferation and differentiation – the epidermis renews because the dermal collagen signal strengthens, not from direct photostimulation of the epidermis

The MMP balance is addressed simultaneously on the degradation side: red LED treatment reverses both collagen downregulation and MMP-1 upregulation in fibroblast models – reducing collagenase activity whilst stimulating synthesis, improving the net collagen balance on both axes. ^[1]

The GHK-Cu connection is particularly notable: topical GHK-Cu applied following red LED irradiation (625–635nm) increased bFGF secretion by approximately 230% and COL1 mRNA expression by approximately 70% compared with LED treatment alone – with P1CP (procollagen I) production increasing by a further 30% – confirming a synergy in which LED-primed fibroblasts respond substantially more strongly to copper peptide stimulation than either intervention produces independently. ^[4] The photobiomodulation context amplifies peptide and growth factor delivery outcomes through the energy provision mechanism – a rationale for timing topical active application alongside or immediately after LED sessions rather than at unrelated routine time points.

Elastin: The LOXL1 Finding

The combined red + NIR study (Li et al. 2021) adds a dimension to the red LED mechanism that most LED content omits: alongside COL1A1 and COL3A1 upregulation, red (640nm) + NIR (830nm) combination treatment significantly upregulated LOXL1 – lysyl oxidase-like 1, the enzyme responsible for cross-linking both collagen and elastin fibres into their functional structural network. ^[5] This finding is mechanistically significant: newly synthesised tropoelastin and procollagen are not functionally integrated into the ECM until LOXL1 cross-links them into mature fibres. Upregulating LOXL1 alongside synthesis genes means LED therapy is promoting not just production but functional maturation of new ECM. ELN (elastin) gene expression was also directly upregulated – confirming that the elastin synthesis benefit extends beyond simply providing cross-linking enzyme for existing tropoelastin production.

Near-Infrared (810–850nm): Depth Extension and Hair Follicle Reach

Near-infrared wavelengths share the CCO photoreceptor mechanism with red light but penetrate substantially deeper into tissue – reaching the reticular dermis and subcutaneous fat rather than primarily the papillary dermis and superficial reticular dermis targeted by red light. The greater depth penetration is a direct consequence of reduced scattering and absorption by tissue components at longer wavelengths – haemoglobin, melanin, and water absorb NIR less strongly than visible red, allowing photons to reach deeper tissue structures. ^[8]

The primary additional target is the dermal papilla – the mesenchymal condensate at the hair follicle base that orchestrates the hair growth cycle through signalling to hair follicle stem cells. NIR penetration to dermal papilla depth provides the energy substrate (via CCO activation) for the highly metabolically demanding DPC-HFSC signalling events at anagen initiation. The vascular network at the dermal level – which NIR irradiance stimulates through CCO activation in endothelial cells – also supports enhanced delivery of growth factors and nutrients to the deeper follicular and dermal compartments. NIR is therefore the mechanistically preferred wavelength for hair thinning and follicle cycle support applications, either as a standalone treatment or in combination with red light for dual-depth rejuvenation.

Blue Light (415–420nm): Porphyrin Mechanism and C. acnes Dosimetry

Blue light at 415–420nm exerts its primary clinical effect through a mechanism entirely distinct from CCO activation: endogenous porphyrin photosensitisation within Cutibacterium acnes. ^[2] C. acnes synthesises coproporphyrin III and other porphyrins as metabolic by-products – these compounds absorb blue light at 415nm with high efficiency, and upon absorption generate singlet oxygen (¹O₂) and ROS within the bacterium. The singlet oxygen disrupts bacterial membrane lipids and protein structures, killing the organism without requiring any exogenous photosensitising agent, antibiotic, or penetration-enhancing vehicle.

The mechanism is inherently resistance-free – porphyrin photosensitisation operates on physical principles (oxidative membrane damage) rather than biological targets that can be mutated or regulated, and no C. acnes resistance to blue light has been documented across any studied strain or phylotype.

The 2023 dosimetry study (PMC10920142) provides the most clinically precise guidance on blue LED efficacy: ^[2]

• All doses tested (25, 50, 75 J/cm²) produced statistically significant C. acnes reduction
• 75 J/cm² produced the most robust bactericidal response
• Serial treatments did not produce cumulative benefit beyond a single optimally dosed session – the dosimetry threshold, once reached, is the operative variable, not repetition frequency
• Stationary phase C. acnes (slow-growing, biofilm-associated) was more susceptible to blue light than exponentially growing cells – a clinically critical finding, because biofilm-phase C. acnes is the population most resistant to topical and oral antibiotics and most associated with inflammatory acne persistence

The barrier recovery finding directly applies here: blue light delays barrier function restoration following disruption – confirmed in the research reference document – making blue-only LED protocols inappropriate in the immediate post-procedure period and suggesting that post-procedure LED should default to red wavelengths rather than combined red-blue protocols until the barrier has re-established. ^[9]

Yellow/Amber Light (590nm): Vascular and Pigmentation Targets

Yellow light at approximately 590nm is absorbed preferentially by haemoglobin in superficial dermal vasculature – a wavelength-specific interaction that produces mild photothermal effects in blood vessels at safe fluences, reducing superficial erythema and vascular irregularity through a mechanism analogous to but considerably gentler than IPL vascular targeting. The opsin-mediated pathway is also relevant at this wavelength, regulating cAMP in keratinocytes and contributing to pigmentation modulation through melanocyte opsin signalling. ^[7]

Yellow LED’s primary clinical applications are post-procedure erythema reduction, rosacea-associated redness management, and post-inflammatory redness – situations where vascular contribution to skin tone irregularity is the primary concern rather than structural collagen or acne pathology. Evidence for yellow LED is less extensively published than for red or blue, but it is mechanistically well-grounded through haemoglobin absorption spectroscopy and the opsin pathway.